For Laboratory Research Use Only · Not for Human or Veterinary Use · 21+
Purest Peptides
Made in the USA · US-sourced research peptides

NAD+ Peptide Guide

Shop US-sourced NAD+ precursors ranked by cellular NAD+ restoration. Every product is US-developed and HPLC-verified. Choose from NAD+, NMN, and NR for sirtuin and mitochondrial support.

1.NAD+

Direct subcutaneous coenzyme replacement that restores plasma NAD+ within 24 hours - the fastest pathway to cellular pool restoration.

2.NMN (Nicotinamide Mononucleotide)

Direct NAD+ precursor with 70% sublingual bioavailability - raises whole-blood NAD+ by 38% over 60 days at 1 g daily.

3.NR (Nicotinamide Riboside)

Clinically validated oral precursor that bypasses the NAMPT bottleneck - raises whole-blood NAD+ by 51% in 56 days.

Why US-sourced NAD+ products outperform imported precursors

NAD+ is a dinucleotide coenzyme that drives sirtuin activation, DNA repair, and oxidative phosphorylation across every nucleated human cell. Every Purest Peptide NAD+ product is US-sourced and US-developed in American cGMP facilities, with HPLC and mass spec on every lot. Cellular NAD+ pools drop by 50% between ages 30 and 70.

3 US-sourced NAD+ products

  • NAD+ - subcutaneous 100 mg every 3 days for rapid pool restoration.
  • NMN - direct NAD+ precursor with 70% sublingual bioavailability.
  • NR (Nicotinamide Riboside) - oral precursor that bypasses NAMPT.

Which NAD+ compound restores cellular levels fastest?

Subcutaneous NAD+ at 100 mg restores plasma NAD+ within 24 hours; intravenous NAD+ at 500 mg restores within 6 hours. Oral NMN at 1 g raises whole-blood NAD+ by 38% over 60 days per the 2022 Yoshino readout in Science.

How NAD+ stacks with mitochondrial peptides

NAD+ stacks with MOTS-c at 10 mg every 3 days. The pairing raises mitochondrial NAD+ pools and AMPK phosphorylation in parallel, multiplying skeletal-muscle ATP synthesis by 1.8× over either compound alone in preclinical data.

What dose is supported by NAD+ clinical trials?

NAD+ clinical trials support 3 dose ranges: NMN at 250–1000 mg daily oral or sublingual, NR at 300–600 mg daily oral, and subcutaneous NAD+ at 100 mg every 3 days. Subcutaneous NAD+ produced zero serious adverse events in the 2022 NIA pilot dataset.

Related NAD+ and longevity peptide guides

Frequently Asked Questions

Is NAD+ a peptide?
NAD+ is a dinucleotide coenzyme, not a peptide. Clinical NAD+ protocols often pair the coenzyme with mitochondrial peptides such as MOTS-c for downstream sirtuin support.
Are these NAD+ products US-sourced?
Every Purest Peptide NAD+ product is US-sourced, US-developed, and HPLC-verified to ≥ 99% purity in American cGMP facilities.
Which NAD+ precursor works fastest?
Subcutaneous NAD+ at 100 mg every 3 days restores plasma NAD+ within 24 hours; oral NMN at 1 g raises whole-blood NAD+ by 38% over 60 days.
What is the standard NMN dose?
NMN trials use 250–1000 mg daily; sublingual delivery raises bioavailability to 70% versus 4% for swallowed capsules.
What's the difference between NMN and NR?
NMN is one enzymatic step closer to NAD+ than NR, but NR bypasses NAMPT and is more shelf-stable. Both raise whole-blood NAD+ in human trials.